Fibroblast Growth Factor Receptor 1 (FGFR1; CD331), FGFR2 and Fibroblast Growth Factor 19 (FGF19) Amplification May Help Predict Sensitivity to FGFR Inhibitors in Cancer

Science-Business eXchange
doi 10.1038/scibx.2012.1067
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Springer Science and Business Media LLC